A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Methotrimeprazine
Estradiol benzoate
The risk or severity of liver enzyme elevations can be increased when Estradiol benzoate is combined with Paritaprevir.
Methotrimeprazine
Estradiol acetate
The risk or severity of liver enzyme elevations can be increased when Estradiol acetate is combined with Paritaprevir.
Methotrimeprazine
Moxestrol
The risk or severity of liver enzyme elevations can be increased when Moxestrol is combined with Paritaprevir.
Methotrimeprazine
Epimestrol
The risk or severity of liver enzyme elevations can be increased when Epimestrol is combined with Paritaprevir.
Methotrimeprazine
Methallenestril
The risk or severity of liver enzyme elevations can be increased when Methallenestril is combined with Paritaprevir.
Methotrimeprazine
Promestriene
The risk or severity of liver enzyme elevations can be increased when Promestriene is combined with Paritaprevir.
Methotrimeprazine
Equol
The risk or severity of liver enzyme elevations can be increased when Equol is combined with Paritaprevir.
Methotrimeprazine
Zeranol
The risk or severity of liver enzyme elevations can be increased when Zeranol is combined with Paritaprevir.
Methotrimeprazine
Esterified estrogens
The risk or severity of liver enzyme elevations can be increased when Esterified estrogens is combined with Paritaprevir.
Methotrimeprazine
Polyestradiol phosphate
The risk or severity of liver enzyme elevations can be increased when Polyestradiol phosphate is combined with Paritaprevir.
Methotrimeprazine
Synthetic Conjugated Estrogens, B
The risk or severity of liver enzyme elevations can be increased when Synthetic Conjugated Estrogens, B is combined with Paritaprevir.
Methotrimeprazine
Synthetic Conjugated Estrogens, A
The risk or severity of liver enzyme elevations can be increased when Synthetic Conjugated Estrogens, A is combined with Paritaprevir.
Methotrimeprazine
Tibolone
The risk or severity of liver enzyme elevations can be increased when Tibolone is combined with Paritaprevir.
Methotrimeprazine
Hexestrol
The risk or severity of liver enzyme elevations can be increased when Hexestrol is combined with Paritaprevir.
Methotrimeprazine
Quinestrol
The risk or severity of liver enzyme elevations can be increased when Quinestrol is combined with Paritaprevir.
Methotrimeprazine
Bempedoic acid
The excretion of Paritaprevir can be decreased when combined with Bempedoic acid.
Methotrimeprazine
Candesartan
The excretion of Paritaprevir can be decreased when combined with Candesartan.
Methotrimeprazine
Elexacaftor
The excretion of Paritaprevir can be decreased when combined with Elexacaftor.
Methotrimeprazine
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Paritaprevir.
Methotrimeprazine
Pexidartinib
The excretion of Paritaprevir can be decreased when combined with Pexidartinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3